| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 40.10B | 41.56B | 39.53B | 36.67B | 35.44B | 31.45B |
| Gross Profit | 8.60B | 9.39B | 8.36B | 7.26B | 6.59B | 6.57B |
| EBITDA | 3.75B | 4.13B | 3.46B | 2.93B | 2.68B | 2.69B |
| Net Income | 2.53B | 1.50B | 2.93B | 1.84B | 1.12B | 2.18B |
Balance Sheet | ||||||
| Total Assets | 51.79B | 51.94B | 53.96B | 50.66B | 47.55B | 47.69B |
| Cash, Cash Equivalents and Short-Term Investments | 11.17B | 10.53B | 13.43B | 12.06B | 11.26B | 10.47B |
| Total Debt | 504.00M | 0.00 | 377.00M | 41.00M | 42.00M | 62.00M |
| Total Liabilities | 12.27B | 12.05B | 14.26B | 12.72B | 11.67B | 11.89B |
| Stockholders Equity | 39.37B | 39.75B | 39.56B | 37.81B | 35.75B | 35.71B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.69B | 1.59B | 1.34B | 755.00M | 750.00M |
| Operating Cash Flow | 0.00 | 1.76B | 4.79B | 3.11B | 1.82B | 1.39B |
| Investing Cash Flow | 0.00 | 790.00M | -5.69B | -228.00M | -214.00M | 157.00M |
| Financing Cash Flow | 0.00 | -2.75B | -1.35B | -906.00M | -1.81B | -2.40B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥176.24B | 15.00 | 10.24% | 2.43% | 7.59% | 9.69% | |
77 Outperform | ¥148.90B | 22.38 | ― | 1.79% | 7.03% | 26.11% | |
69 Neutral | ¥921.50B | 16.33 | 27.58% | 0.99% | 8.43% | 225.40% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥1.60T | 10.41 | 3.37% | 1.85% | 0.85% | 8.37% | |
60 Neutral | ¥27.47B | 20.02 | ― | 3.23% | 5.15% | -47.45% | |
54 Neutral | ¥108.32B | -36.94 | 2.80% | 3.38% | -4.52% | -91.68% |